D Molecular Therapeutics, Inc. ( (FDMT) ) has released its Q3 earnings. Here is a breakdown of the information 4D Molecular Therapeutics, Inc.

To protect your eye health and support your vision, these are 10 simple things you can do every day for your eyes.

Presented positive interim data for 4D-150 in wet age-related macular degeneration (wet AMD) from PRISM Phase 1/2 clinical trial highlighting ...

Patch 2.13, a new update for Cyberpunk 2077 and Phantom Liberty that delivers support for not only AMD FidelityFX Super Resolution 3 with Frame Generation, but also Intel’s Xe Super Sampling 1.3 ...

Afqlir® (aflibercept) approved to treat various retinal diseases, including neovascular age-related macular degeneration ...

Meta's AI capabilities may soon expand Instagram's feature set, allowing users to personalize their profiles with ...

Kodiak Sciences Inc. , today reported business highlights and financial results for the quarter ended September 30, 2024. "In the third quarter we hosted an Investor R&D Day in New York," said Victor ...

Presented positive interim data for 4D-150 in wet age-related macular degeneration (wet AMD) from PRISM Phase 1/2 clinical trial highlighting robust and durable clinical activity across diverse patien ...

Additionally, logistic regression was performed to evaluate the relationship between baseline CT and CVI and the progression of AMD. The results showed that the mean age of the patients was 77.1 years ...

Belite Bio, Inc. ( NASDAQ: BLTE) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Tom Lin - Chairman and Chief Executive Officer Hendrik Scholl - Chief Medical Officer Nathan Mata - Chief ...

When it comes to screening for retinopathy of prematurity (ROP), age-related macular degeneration (AMD), and diabetic retinopathy (DR ... lifestyle factors, and disease progression trends, allowing ...

SOL-1 expected to be fully randomized by YE 2024 with topline data expected in Q4 2025 Active clinical trial sites now enrolling patients d ...